We need more clinical trials examining the cardiac benefits of SGLT2 inhibitors and GLP-1 agonists for patients prescribed insulin, but with more information on diabetes control and the extent of that benefit provided as the diabetes control is worse. For more information: Joanna Khatib, MBBS , can be reached at [email protected].
And as I quickly learned, hydration isnt just about water anymore
Because GLP-1 medications can lead to rapid weight loss, some patients may lose significant lean muscle mass during treatment
Some researchers transition to other fat loss peptides or longevity-focused protocols after completing a retatrutide cycle, using the metabolic improvements as a foundation for further optimization
Consider whether accepting higher weight is preferable to permanent intensive effort, or whether finding financial resources for chronic treatment is possible
Anatomy and histology of the human and murine prostate